Valley National Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $135K | Buy |
268
+4
| +2% | +$1.92K | 0.02% | 302 |
|
|
2026
Q1 | $128K | Sell |
264
-17
| -6% | -$9.23K | 0.02% | 290 |
|
|
2025
Q4 | $162K | Buy |
281
+27
| +11% | +$15.3K | 0.02% | 264 |
|
|
2025
Q3 | $122K | Sell |
254
-3,028
| -92% | -$1.41M | 0.02% | 280 |
|
|
2025
Q2 | $1.33M | Buy |
3,282
+50
| +2% | +$20.9K | 0.22% | 113 |
|
|
2025
Q1 | $1.61M | Buy |
3,232
+123
| +4% | +$66.6K | 0.29% | 90 |
|
|
2024
Q4 | $1.62M | Buy |
3,109
+268
| +9% | +$147K | 0.29% | 92 |
|
|
2024
Q3 | $1.76M | Buy |
2,841
+2,727
| +2,392% | +$1.61M | 0.32% | 89 |
|
|
2024
Q2 | $63K | Buy |
114
+1
| +0.9% | +$573 | 0.01% | 360 |
|
|
2024
Q1 | $65K | Buy |
113
+14
| +14% | +$7.86K | 0.01% | 375 |
|
|
2023
Q4 | $52K | Sell |
99
-12
| -11% | -$5.81K | 0.01% | 395 |
|
|
2023
Q3 | $56K | Buy |
111
+32
| +41% | +$17.1K | 0.01% | 373 |
|
|
2023
Q2 | $42K | Buy |
79
+5
| +7% | +$2.7K | 0.01% | 417 |
|
|
2023
Q1 | $43K | Sell |
74
-4
| -5% | -$2.25K | 0.01% | 405 |
|
|
2022
Q4 | $45K | Sell |
78
-24
| -24% | -$12.7K | 0.01% | 393 |
|
|
2022
Q3 | $54K | Buy |
102
+30
| +42% | +$16.8K | 0.01% | 368 |
|
|
2022
Q2 | $40K | Buy |
72
+2
| +3% | +$1.1K | 0.01% | 381 |
|
|
2022
Q1 | $41K | Buy |
70
+8
| +13% | +$4.6K | 0.01% | 407 |
|
|
2021
Q4 | $41K | Buy |
62
+4
| +7% | +$2.5K | 0.01% | 396 |
|
|
2021
Q3 | $33K | Buy |
58
+8
| +16% | +$4.39K | 0.01% | 397 |
|
|
2021
Q2 | $25K | Buy |
50
+4
| +9% | +$1.89K | ﹤0.01% | 457 |
|
|
2021
Q1 | $21K | Buy |
46
+3
| +7% | +$1.43K | ﹤0.01% | 449 |
|
|
2020
Q4 | $20K | Hold |
43
| – | – | ﹤0.01% | 434 |
|
|
2020
Q3 | $19K | Hold |
43
| – | – | ﹤0.01% | 406 |
|
|
2020
Q2 | $16K | Buy |
43
+20
| +87% | +$6.7K | ﹤0.01% | 428 |
|
|
2020
Q1 | $7K | Sell |
23
-21
| -48% | -$6.62K | ﹤0.01% | 514 |
|
|
2019
Q4 | $14K | Hold |
44
| – | – | ﹤0.01% | 483 |
|
|
2019
Q3 | $13K | Buy |
44
+21
| +91% | +$6.01K | ﹤0.01% | 485 |
|
|
2019
Q2 | $7K | Hold |
23
| – | – | ﹤0.01% | 521 |
|
|
2019
Q1 | $6K | Hold |
23
| – | – | ﹤0.01% | 548 |
|
|
2018
Q4 | $5K | Hold |
23
| – | – | ﹤0.01% | 535 |
|
|
2018
Q3 | $6K | Hold |
23
| – | – | ﹤0.01% | 497 |
|
|
2018
Q2 | $5K | Buy |
23
+11
| +92% | +$2.33K | ﹤0.01% | 488 |
|
|
2018
Q1 | $2K | Hold |
12
| – | – | ﹤0.01% | 561 |
|
|
2017
Q4 | $2K | Hold |
12
| – | – | ﹤0.01% | 572 |
|
|
2017
Q3 | $2K | Hold |
12
| – | – | ﹤0.01% | 570 |
|
|
2017
Q2 | $2K | Hold |
12
| – | – | ﹤0.01% | 539 |
|
|
2017
Q1 | $2K | Sell |
12
-111
| -90% | -$17K | ﹤0.01% | 541 |
|
|
2016
Q4 | $17K | Hold |
123
| – | – | 0.01% | 343 |
|
|
2016
Q3 | $20K | Hold |
123
| – | – | 0.01% | 306 |
|
|
2016
Q2 | $18K | Hold |
123
| – | – | 0.01% | 321 |
|
|
2016
Q1 | $17K | Hold |
123
| – | – | 0.01% | 324 |
|
|
2015
Q4 | $17K | Buy |
123
+6
| +5% | +$800 | 0.01% | 320 |
|
|
2015
Q3 | $14K | Sell |
117
-8
| -6% | -$1.04K | 0.01% | 340 |
|
|
2015
Q2 | $16K | Hold |
125
| – | – | 0.01% | 332 |
|
|
2015
Q1 | $17K | Buy |
+125
| New | +$16.1K | 0.01% | 315 |
|
Other funds holding TMO
Valley National Advisers's TMO Position: Q2 2026 in Review
Valley National Advisers increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $1.92K and bringing the position to 268 shares worth $135K. The position accounts for 0.02% of the portfolio, ranked #302.
Valley National Advisers first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.76M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Valley National Advisers held 268 shares of Thermo Fisher Scientific worth $135K as of Q2 2026.
- Valley National Advisers bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
- Thermo Fisher Scientific made up 0.02% of Valley National Advisers's portfolio in Q2 2026, its #302 holding.
- Valley National Advisers first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
- Valley National Advisers's Thermo Fisher Scientific position peaked at $1.76M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.